Hosted on MSN1mon
Biohaven's troriluzole gains FDA priority review for SCASCA, a rare and life-threatening neurodegenerative ... analysis and 8 additional key insights about Biohaven's financial health and market position. Biohaven's clinical development program for ...
SCA is a serious condition where the heart suddenly stops beating. It can be deadly and is responsible for many heart-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results